Cargando…
CHST4 might promote the malignancy of cholangiocarcinoma
BACKGROUND: Cholangiocarcinoma (CCA) is reported as an aggressive cancer which leads to high mortality and no effective therapeutic target has yet been discovered. Surgical resection is the main method to treat patients with CCA. However, only one-third of CCA patients have the opportunity to accept...
Autores principales: | Zhang, Guanran, Liu, Xuyue, Jian, Aiwen, Zheng, Kexin, Wang, Haiyan, Hao, Jing, Zhi, Sujuan, Zhang, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926211/ https://www.ncbi.nlm.nih.gov/pubmed/35294478 http://dx.doi.org/10.1371/journal.pone.0265069 |
Ejemplares similares
-
A2M is a potential core gene in intrahepatic cholangiocarcinoma
por: Zhang, Guanran, et al.
Publicado: (2022) -
A New Signature of Sarcoma Based on the Tumor Microenvironment Benefits Prognostic Prediction
por: Zhang, Guanran, et al.
Publicado: (2023) -
The LINC00452/miR-204/CHST4 Axis Regulating Thymic Tregs Might Be Involved in the Progression of Thymoma-Associated Myasthenia Gravis
por: Wang, Fuqiang, et al.
Publicado: (2022) -
Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a
por: Liu, Yang, et al.
Publicado: (2022) -
Sohlh2 promotes pulmonary fibrosis via repression of p62/Keap1/Nrf2 mediated anti-oxidative signaling pathway
por: Liu, Lanlan, et al.
Publicado: (2023)